Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial.
Pengfei JinXiling GuoWei ChenShihua MaHongxing PanLianpan DaiPan DuLili WangLai-Run JinYin ChenFengjuan ShiJingxian LiuXiaoyu XuYanan ZhangGeorge Fu GaoCancan ChenJialu FengJingxin LiFeng-Cai ZhuPublished in: PLoS medicine (2022)
Study on Heterologous Prime-boost of Recombinant COVID-19 Vaccine (Ad5 Vector) and RBD-based Protein Subunit Vaccine; ClinicalTrial.gov NCT04833101.